COSCIENS Biopharma Inc. CSCI
2.72 USD 0.00 (+0.00%)
Regular-session close
2.72 Day range 2.72
2.50 52-week range 11.10
- YTD
- +33.99%
- 1 year
- +33.99%
CSCI revenue history
Revenue is income from the company’s ordinary business activities.
9,587,000 USD
FY 2024 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | 9,587,000 | 2,444,000 | 34.22% |
| FY 2023 | 2023-12-31 | 7,143,000 | -7,429,000 | -50.98% |
| FY 2022 | 2022-12-31 | 14,572,000 | 9,312,000 | 177.03% |
| FY 2021 | 2021-12-31 | 5,260,000 | 1,608,000 | 44.03% |
| FY 2020 | 2020-12-31 | 3,652,000 | 3,120,000 | 586.47% |
| FY 2019 | 2019-12-31 | 532,000 | -26,349,000 | -98.02% |
| FY 2018 | 2018-12-31 | 26,881,000 | 25,958,000 | 2812.35% |
| FY 2017 | 2017-12-31 | 923,000 | 12,000 | 1.32% |
| FY 2016 | 2016-12-31 | 911,000 | 366,000 | 67.16% |
| FY 2015 | 2015-12-31 | 545,000 | 534,000 | 4854.55% |
| FY 2014 | 2014-12-31 | 11,000 | -6,164,000 | -99.82% |
| FY 2013 | 2013-12-31 | 6,175,000 | 4,122,000 | 200.78% |
| FY 2012 | 2012-12-31 | 2,053,000 | -2,652,000 | -56.37% |
| FY 2011 | 2011-12-31 | 4,705,000 | -22,998,000 | -83.02% |
| FY 2010 | 2010-12-31 | 27,703,000 | -35,534,000 | -56.19% |
| FY 2009 | 2009-12-31 | 63,237,000 | 24,759,000 | 64.35% |
| FY 2008 | 2008-12-31 | 38,478,000 | -3,590,000 | -8.53% |
| FY 2007 | 2007-12-31 | 42,068,000 | 3,269,000 | 8.43% |
| FY 2006 | 2006-12-31 | 38,799,000 | -6,014,000 | -13.42% |
| FY 2005 | 2005-12-31 | 44,813,000 | 1,841,000 | 4.28% |
| FY 2004 | 2004-12-31 | 42,972,000 | -75,768,000 | -63.81% |
| FY 2003 | 2003-12-31 | 118,740,000 | 40,812,920 | 52.37% |
| FY 2002 | 2002-12-31 | 77,927,080 | 44,218,790 | 131.18% |
| FY 2001 | 2001-12-31 | 33,708,290 | 27,236,440 | 420.84% |
| FY 2000 | 2000-12-31 | 6,471,850 | 1,730,324 | 36.49% |
| FY 1999 | 1999-12-31 | 4,741,526 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-08-15T15:35:03.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.